Immediate Impact
24 standout
Citing Papers
EASL Clinical Practice Guidelines on hepatitis delta virus
2023 Standout
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
2023 Standout
Works of Bita Behnava being referenced
Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials
2016
Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bita Behnava | 550 | 517 | 36 | 36 | 55 | 621 | |
| Manabu Masuzawa | 543 | 492 | 29 | 82 | 43 | 721 | |
| B. Berris | 334 | 422 | 23 | 37 | 42 | 596 | |
| Themistoklis Vassiliadis | 363 | 417 | 33 | 81 | 28 | 641 | |
| Ana de Lourdes Candolo Martinelli | 360 | 414 | 36 | 27 | 50 | 581 | |
| Yu Wang | 304 | 302 | 25 | 76 | 39 | 560 | |
| V. Carreño | 522 | 477 | 97 | 40 | 33 | 716 | |
| Janett Fischer | 380 | 511 | 15 | 23 | 40 | 631 | |
| Giovanni Faria Silva | 290 | 272 | 40 | 29 | 71 | 539 | |
| Shozo Miyake | 427 | 346 | 33 | 71 | 37 | 627 | |
| Kouichi Takaguchi | 494 | 484 | 8 | 44 | 31 | 594 |
All Works
Login with ORCID to disown or claim papers
Loading papers...